![Susan Altschuller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Altschuller
Directeur Financier/CFO chez
CLIMB BIO, INC.
Profil
Susan Altschuller is currently Director at Vestaron Corp., Founding Member at HNRNP Family Foundation, and Treasurer, Chief Financial & Accounting Officer at Climb Bio, Inc. Former roles include Independent Director at Mural Oncology Plc, Head-Investor Relations at Biogen, Inc., Head-Enterprise Finance at Alexion Pharmaceuticals, Inc., Chief Financial Officer at Dragonfly Therapeutics, Inc., Head-Investor Relations at Bioverativ, Inc., Chief Financial Officer & Senior Vice President at ImmunoGen, Inc., and Chief Financial Officer at Cerevel Therapeutics Holdings, Inc. and Cerevel Therapeutics, Inc. Education includes a doctorate from Illinois Institute of Technology, an undergraduate degree from Tulane University (Louisiana), and an MBA from MIT Sloan School of Management.
Dernières actualités sur Susan Altschuller
Postes actifs de Susan Altschuller
| Sociétés | Poste | Début |
|---|---|---|
| CLIMB BIO, INC. | Directeur Financier/CFO | 01/10/2025 |
Vestaron Corp.
 Vestaron Corp. Chemicals: AgriculturalProcess Industries Manufactures crop protection insecticides | Directeur/Membre du Conseil | - |
Anciens postes connus de Susan Altschuller
| Sociétés | Poste | Fin |
|---|---|---|
Dragonfly Therapeutics, Inc.
 Dragonfly Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and produces drugs for autoimmune disease, oncology, fibrosis & neuro-inflammation | Directeur Financier/CFO | 01/12/2024 |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Directeur Financier/CFO | 01/08/2024 |
Cerevel Therapeutics, Inc.
 Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Directeur Financier/CFO | 01/08/2024 |
| IMMUNOGEN, INC. | Directeur Financier/CFO | 01/03/2023 |
Formation de Susan Altschuller
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Vestaron Corp.
Vestaron Corp. Chemicals: AgriculturalProcess Industries Manufactures crop protection insecticides | Process Industries |
Illinois Institute of Technology
 Illinois Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and produces drugs for autoimmune disease, oncology, fibrosis & neuro-inflammation | Commercial Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Health Technology |
